LEWIS JOSEPH — SEC insider filings
SEC reporting owner CIK 1015747. 40 insider filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 40 filings on record, filed 2020-09-01 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 31 legs across 15 filings — 11,030,655 shares, $173,404,599 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 66 legs across 11 filings — 5,457,587 shares, $303,756,531 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 63.
- Largest priced transaction: sale of 362,950 shares @ $202.00 ($73,315,900) in Mirati Therapeutics, Inc., filed 2020-10-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mirati Therapeutics, Inc. (MRTX) | — | 7 | 4 legs · 2,517,946 sh · $69,998,899 | 40 legs · 1,212,386 sh · $239,042,266 | 29 |
| iTeos Therapeutics, Inc. (ITOS) | — | 4 | — | 18 legs · 1,625,201 sh · $58,544,150 | 1 |
| Odonate Therapeutics, Inc. (ODT) | 10% owner | 6 | 9 legs · 2,243,709 sh · $33,167,218 | 5 legs · 1,400,000 sh · $2,686,115 | — |
| Tango Therapeutics, Inc. (TNGX) | — | 7 | 12 legs · 3,394,000 sh · $21,649,920 | 2 legs · 225,000 sh · $2,240,250 | 3 |
| Rain Oncology Inc. (RAIN) | — | 2 | 3 legs · 1,175,000 sh · $19,848,250 | 1 leg · 995,000 sh · $1,243,750 | 2 |
| PMV Pharmaceuticals, Inc. (PMVP) | — | 1 | 1 leg · 950,000 sh · $17,100,000 | — | 8 |
| Tyra Biosciences, Inc. (TYRA) | — | 3 | 2 legs · 750,000 sh · $11,640,312 | — | 8 |
| INSEEGO CORP. (INSG) | 10% owner | 10 | — | — | 12 |
Insider filings — LEWIS JOSEPH
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Holdings, Inc. | Grant/award (A): 19,654 @ $0 | EDGAR |
| 2025-09-15 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Holdings, Inc. | Grant/award (A): 9,427 @ $0 | EDGAR |
| 2024-11-12 | 4 | INSEEGO CORP. (INSG) jointly with Golden Harbor Ltd. | Other (J): 697,736 · Other (J): 453,528 (derivative) | EDGAR |
| 2024-10-02 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Holdings, Inc. | Grant/award (A): 7,655 @ $0 | EDGAR |
| 2024-07-02 | 4 | INSEEGO CORP. (INSG) | Grant/award (A): 465,385 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., Davis Aaron I. | Grant/award (A): 1,142,857 @ $17.50 | EDGAR |
| 2024-02-08 | 4 | Tyra Biosciences, Inc. (TYRA) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Grant/award (A): 63,412 @ $13.01 · Grant/award (A): 705,280 (derivative) @ $13.01 | EDGAR |
| 2024-01-25 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I., Dissanayake Shehan Bharatha, Fuglesang Christopher, Braslyn Ltd., Lockend Five, LLC | Disposition to issuer (D): 287,866 · Disposition to issuer (D): 3,201,440 · Disposition to issuer (D): 203,754 · Disposition to issuer (D): 3,135,966 · Disposition to issuer (D): 30,518 · Disposition to issuer (D): 332,809 (derivative) · +2 more | EDGAR |
| 2023-10-17 | 4/A | Tango Therapeutics, Inc. (TNGX) jointly with Boxer Capital, LLC, Davis Aaron I., MVA Investors, LLC, Boxer Asset Management Inc. | Purchase (P): 750,000 @ $7.07 · Purchase (P): 500,000 @ $6.84 | EDGAR |
| 2023-10-17 | 4 | Tango Therapeutics, Inc. (TNGX) jointly with Boxer Capital, LLC, Davis Aaron I., MVA Investors, LLC, Boxer Asset Management Inc. | Purchase (P): 750,000 @ $7.07 · Purchase (P): 500,000 @ $6.84 | EDGAR |
| 2023-10-11 | 4/A | Tango Therapeutics, Inc. (TNGX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Grant/award (A): 475,000 @ $5.15 · Grant/award (A): 2,340,579 (derivative) @ $5.15 | EDGAR |
| 2023-10-11 | 4 | Tango Therapeutics, Inc. (TNGX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Sale (S): 50,000 @ $9.91 · Sale (S): 175,000 @ $9.97 | EDGAR |
| 2023-10-03 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Financial, LLC | Grant/award (A): 215,517 @ $0 | EDGAR |
| 2023-08-25 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., Davis Aaron I. | Sale (S): 34,846 @ $14.19 · Sale (S): 95,516 @ $15.63 · Sale (S): 219,638 @ $16.87 | EDGAR |
| 2023-08-15 | 4 | Tango Therapeutics, Inc. (TNGX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Purchase (P): 475,000 @ $5.15 · Purchase (P): 2,340,579 (derivative) @ $5.15 | EDGAR |
| 2023-08-15 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I., Dissanayake Shehan Bharatha, Fuglesang Christopher | Purchase (P): 57,533 @ $27.80 · Purchase (P): 1,201,440 @ $27.80 | EDGAR |
| 2023-08-15 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I., Dissanayake Shehan Bharatha, Fuglesang Christopher | Purchase (P): 57,533 @ $27.80 · Purchase (P): 1,201,440 @ $27.80 | EDGAR |
| 2023-05-24 | 4 | Rain Oncology Inc. (RAIN) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., Davis Aaron I. | Sale (S): 995,000 @ $1.25 | EDGAR |
| 2022-10-13 | 4 | Tango Therapeutics, Inc. (TNGX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Purchase (P): 117,000 @ $4.25 · Purchase (P): 50,000 @ $4.43 · Purchase (P): 70,000 @ $4.65 | EDGAR |
| 2022-10-06 | 4 | Tango Therapeutics, Inc. (TNGX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Purchase (P): 25,606 @ $3.67 · Purchase (P): 45,500 @ $3.93 · Purchase (P): 40,500 @ $3.84 · Purchase (P): 70,394 @ $4.06 | EDGAR |
| 2022-08-05 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Financial, LLC | Grant/award (A): 49,801 @ $0 | EDGAR |
| 2022-03-18 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Sale (S): 575,201 @ $35.25 | EDGAR |
| 2022-01-05 | 4 | iTeos Therapeutics, Inc. (ITOS) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Sale (S): 432,903 @ $47.65 · Sale (S): 39,481 @ $49.37 · Sale (S): 17,173 @ $50.63 · Sale (S): 23,353 @ $47.63 · Sale (S): 1,682 @ $49.37 · Sale (S): 731 @ $50.63 · +8 more | EDGAR |
| 2021-12-21 | 4 | Tyra Biosciences, Inc. (TYRA) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Purchase (P): 125,000 @ $13.12 | EDGAR |
| 2021-11-24 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Sale (S): 200,000 @ $1.55 · Sale (S): 200,000 @ $1.57 | EDGAR |
| 2021-11-19 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Sale (S): 600,000 @ $2.17 · Sale (S): 250,000 @ $1.95 · Sale (S): 150,000 @ $1.84 | EDGAR |
| 2021-09-24 | 4 | INSEEGO CORP. (INSG) jointly with Golden Harbor Ltd. | Grant/award (A): 1,067,645 @ $0 · Disposition to issuer (D): 7,000 @ $0 | EDGAR |
| 2021-09-17 | 4 | Tyra Biosciences, Inc. (TYRA) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Conversion (C): 5,698,359 · Purchase (P): 625,000 @ $16 · Conversion (C): 288,095 · Conversion (C): 1,480,242 (derivative) @ $0 · Conversion (C): 95,516 (derivative) @ $0 · Conversion (C): 713,629 (derivative) @ $0 · +1 more | EDGAR |
| 2021-07-30 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Financial, LLC | Grant/award (A): 14,221 @ $0 | EDGAR |
| 2021-05-11 | 4 | INSEEGO CORP. (INSG) jointly with Tavistock Financial, LLC | Grant/award (A): 6,242 @ $0 | EDGAR |
| 2021-04-27 | 4 | Rain Therapeutics Inc. (RAIN) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Purchase (P): 25,000 @ $15.58 · Purchase (P): 125,000 @ $16.27 · Purchase (P): 1,025,000 @ $17 · Conversion (C): 3,263,986 (derivative) @ $0 · Conversion (C): 3,022,489 (derivative) @ $0 | EDGAR |
| 2021-03-10 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Braslyn Ltd. | Sale (S): 1,107 @ $195.82 · Sale (S): 4,633 @ $197.30 · Sale (S): 3,993 @ $197.81 · Sale (S): 2,237 @ $199.08 · Option exercise (M): 11,971 @ $0.00 · Sale (S): 1 @ $191 · +7 more | EDGAR |
| 2021-03-09 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I., LIEBERBURG IVAN M, Dissanayake Shehan Bharatha, Fuglesang Christopher | Option exercise (M): 13,996 @ $0.00 · Sale (S): 1 @ $181 · Sale (S): 37,000 @ $181.15 · Option exercise (M): 597,444 @ $0.00 · Sale (S): 4 @ $181 · Sale (S): 363,000 @ $181.15 · +3 more | EDGAR |
| 2020-12-30 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Purchase (P): 75,000 @ $16.90 · Purchase (P): 225,000 @ $17.11 · Purchase (P): 100,000 @ $17.46 | EDGAR |
| 2020-10-30 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Braslyn Ltd. | Sale (S): 44,959 @ $203.35 · Sale (S): 38,543 @ $204.57 · Sale (S): 45,896 @ $205.49 · Sale (S): 41,266 @ $206.50 · Sale (S): 38,525 @ $207.35 · Sale (S): 25,036 @ $208.40 · +25 more | EDGAR |
| 2020-10-30 | 4 | Mirati Therapeutics, Inc. (MRTX) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I., LIEBERBURG IVAN M, Dissanayake Shehan Bharatha, Fuglesang Christopher | Sale (S): 37,050 @ $202 · Option exercise (M): 37,051 @ $0.00 · Tax withholding (F): 1 @ $219.97 · Sale (S): 362,950 @ $202 · Option exercise (M): 362,952 @ $0.00 · Tax withholding (F): 2 @ $219.97 · +2 more | EDGAR |
| 2020-09-30 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Purchase (P): 93,200 @ $13.03 · Purchase (P): 122,000 @ $14.08 | EDGAR |
| 2020-09-29 | 4 | PMV Pharmaceuticals, Inc. (PMVP) jointly with Boxer Capital, LLC, Boxer Asset Management Inc., MVA Investors, LLC, Davis Aaron I. | Purchase (P): 950,000 @ $18 · Conversion (C): 586,099 · Conversion (C): 732,137 · Conversion (C): 32,708 · Conversion (C): 28,129 · Conversion (C): 586,099 (derivative) @ $0 · +3 more | EDGAR |
| 2020-09-09 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Purchase (P): 125,100 @ $14.89 · Purchase (P): 18,800 @ $14.69 · Purchase (P): 81,100 @ $15.20 | EDGAR |
| 2020-09-01 | 4 | Odonate Therapeutics, Inc. (ODT) jointly with Boxer Capital, LLC, Boxer Asset Management Inc. | Purchase (P): 1,403,509 @ $14.25 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1015747 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs